WCN26-4414 Impact of Rapid Glucocorticoid Tapering in Pure Membranous Lupus Nephritis

Read full text Summarise with VIRAT
Authors: Hidekazu Ikeuchi, Keiju Hiromura, Hayato Shimizu, Shuji Sumitomo, Yoshiya Tanaka, Hiroki Hayashi, Satoshi Kubo, Shingo Nakayamada, Yukio Yuzawa, Michihito Kono, Tatsuya Atsumi, Koichiro Ohmura
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

While rapid glucocorticoid (GC) tapering is increasingly advocated in proliferative lupus nephritis (LN), evidence regarding this approach in pure membranous LN (Class V) remains limited. Given the distinct pathophysiology and traditionally variable treatment strategies for Class V disease, the safety and efficacy of reducing GC to low doses within six months warrant clarification. We aimed to evaluate the impact of rapid GC tapering on renal outcomes in patients with biopsy-confirmed pure membranous LN.

Fields of Study & Subjects

Systemic Lupus Erythematosus Research Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106226–106226
Publication date
25 March 2026
Language
EN